Jumpei Taniguchi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right-to-reply.

Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right-to-reply.

Journal: The Journal of antimicrobial chemotherapy

Published: June 11, 2026

Development and validation of the N-DROP score: A penalized logistic regression model for predicting 30-day in-hospital mortality in patients with nursing- and healthcare-associated pneumonia.

Development and validation of the N-DROP score: A penalized logistic regression model for predicting 30-day in-hospital mortality in patients with nursing- and healthcare-associated pneumonia.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: May 30, 2026

Response to the Letter "Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study".

Response to the Letter "Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study".

Journal: Pharmacoepidemiology and drug safety

Published: May 10, 2026

Real-world prescribing patterns of inhaled corticosteroid-containing inhalers following acute respiratory tract infections: A nationwide claims database study.

Real-world prescribing patterns of inhaled corticosteroid-containing inhalers following acute respiratory tract infections: A nationwide claims database study.

Journal: Respiratory medicine

Published: March 12, 2026

Comparison of oral third- versus first-/ second-generation cephalosporins for acute uncomplicated cystitis: a nationwide retrospective cohort study.

Comparison of oral third- versus first-/ second-generation cephalosporins for acute uncomplicated cystitis: a nationwide retrospective cohort study.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: December 23, 2025

Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study.

Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study.

Journal: Pharmacoepidemiology and drug safety

Published: December 10, 2025

Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right to reply-authors' response.

Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right to reply-authors' response.

Journal: The Journal of antimicrobial chemotherapy

Published: September 08, 2025

Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective cohort study.

Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective cohort study.

Journal: British journal of clinical pharmacology

Published: August 19, 2025

Clinical characteristics and healthcare resource utilization among patients hospitalized for pulmonary tuberculosis: A national inpatient database study in Japan.

Clinical characteristics and healthcare resource utilization among patients hospitalized for pulmonary tuberculosis: A national inpatient database study in Japan.

Journal: Respiratory investigation

Published: July 31, 2025

Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-authors' response.

Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-authors' response.

Journal: The Journal of antimicrobial chemotherapy

Published: July 21, 2025

Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan.

Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: June 02, 2025

Mortality after broad- versus narrow-spectrum antibiotic treatment for patients with nursing and healthcare-associated pneumonia: A nationwide retrospective cohort study.

Mortality after broad- versus narrow-spectrum antibiotic treatment for patients with nursing and healthcare-associated pneumonia: A nationwide retrospective cohort study.

Journal: Journal of hospital medicine

Published: May 19, 2025

Showing 1-12 of 40

Last Updated: 09/26/2026